One under-$10 stock that's quickly moving within range of triggering a near-term breakout trade is
Rosetta Genomics (
ROSG), which develops diagnostic tests and therapeutic tools. This stock is off to a slow start in 2013, with shares down by 17%.
If you take a look at the chart for Rosetta Genomics, you'll notice that this stock recently spiked sharply higher back above its 50-day moving average at $3.72 a share with heavy upside volume. That move is quickly pushing shares of ROSG within range of triggering a near-term breakout trade.
>>3 Health Care Stocks Under $10 to Watch
Traders should now look for long-biased trades in ROSG if it manages to break out above some near-term overhead resistance at $4.22 a share and then once it takes its 200-day moving average at $4.64 a share to $4.70 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 286,655 shares. If that breakout triggers soon, then ROSG will set up to re-test or possibly take out its next major overhead resistance levels at $5.25 to $5.50 a share. Any high-volume move above those levels will then put its nest major overhead resistance levels at $6 to $7.70 into range for shares of ROSG.
Traders can look to buy ROSG off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day at $3.72 a share or below some more near-term support at $3.62 a share One can also buy ROSG off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage below your entry point.
This stock is a favorite target of the short-sellers, since the current short interest as a percentage of the float for ROSG is very high at $16.8%. When you combine that with its low float of just 9 million shares, you've all the ingredients for a powerful short-squeeze if ROSG triggers that breakout soon.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts